Romglizone en es it fr

Romglizone Brand names, Romglizone Analogs

Romglizone Brand Names Mixture

  • No information avaliable

Romglizone Chemical_Formula


Romglizone RX_link

Romglizone fda sheet

Romglizone FDA

Romglizone msds (material safety sheet)

Romglizone Synthesis Reference

No information avaliable

Romglizone Molecular Weight

441.541 g/mol

Romglizone Melting Point

184-186 oC

Romglizone H2O Solubility

No information avaliable

Romglizone State


Romglizone LogP

No information avaliable

Romglizone Dosage Forms

No information avaliable

Romglizone Indication

For the treatment of Type II diabetes mellitus

Romglizone Pharmacology

Troglitazone is an oral antihyperglycemic agent which acts primarily by decreasing insulin resistance. Troglitazone is used in the management of type II diabetes (noninsulin-dependent diabetes mellitus (NIDDM) also known as adult-onset diabetes). It improves sensitivity to insulin in muscle and adipose tissue and inhibits hepatic gluconeogenesis. Troglitazone is not chemically or functionally related to either the sulfonylureas, the biguanides, or the g-glucosidase inhibitors. Troglitazone may be used concomitantly with a sulfonylurea or insulin to improve glycemic control.

Romglizone Absorption

Absorbed rapidly. Food increases the extent of absorption by 30% to 85%.

Romglizone side effects and Toxicity

No information avaliable

Romglizone Patient Information


Follow the links

Romglizone Organisms Affected

Humans and other mammals